Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels The VIDA Randomized Clinical Trial

被引:206
作者
Castro, Mario [1 ]
King, Tonya S. [2 ]
Kunselman, Susan J. [2 ]
Cabana, Michael D. [3 ]
Denlinger, Loren [4 ]
Holguin, Fernando [5 ]
Kazani, Shamsah D. [6 ]
Moore, Wendy C. [7 ]
Moy, James [8 ]
Sorkness, Christine A. [4 ]
Avila, Pedro [9 ]
Bacharier, Leonard B. [1 ]
Bleecker, Eugene [7 ]
Boushey, Homer A. [3 ]
Chmiel, James [10 ]
Fitzpatrick, Anne M. [11 ]
Gentile, Deborah [12 ]
Hundal, Mandeep [13 ]
Israel, Elliot [6 ]
Kraft, Monica [13 ]
Krishnan, Jerry A. [14 ]
LaForce, Craig [15 ]
Lazarus, Stephen C. [3 ]
Lemanske, Robert [4 ]
Lugogo, Njira [13 ]
Martin, Richard J. [16 ]
Mauger, David T. [2 ]
Naureckas, Edward [17 ]
Peters, Stephen P. [7 ]
Phipatanakul, Wanda [18 ]
Que, Loretta G. [13 ]
Sheshadri, Ajay [1 ]
Smith, Lewis [9 ]
Solway, Julian [17 ]
Sullivan-Vedder, Lisa [19 ]
Sumino, Kaharu [1 ]
Wechsler, Michael E. [16 ]
Wenzel, Sally [5 ]
White, Steven R. [17 ]
Sutherland, E. Rand [16 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Penn State Univ, Hershey, PA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Wisconsin, Madison, WI 53706 USA
[5] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[6] Brigham & Womens Hosp, Boston, MA 02115 USA
[7] Wake Forest Sch Med, Winston Salem, NC USA
[8] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
[9] Northwestern Univ, Chicago, IL 60611 USA
[10] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[11] Emory Univ, Atlanta, GA 30322 USA
[12] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[13] Duke Univ, Sch Med, Durham, NC USA
[14] Univ Illinois, Chicago, IL USA
[15] North Carolina Clin Res, Raleigh, NC USA
[16] Natl Jewish Hlth, Denver, CO USA
[17] Univ Chicago, Chicago, IL 60637 USA
[18] Boston Childrens Hosp, Boston, MA USA
[19] Aurora Sinai Med Ctr, Milwaukee, WI USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 311卷 / 20期
关键词
INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; LUNG-FUNCTION; RESPONSIVENESS; MONTELUKAST; ASSOCIATION; RELIABILITY; EXPRESSION; CHILDHOOD; INDUCTION;
D O I
10.1001/jama.2014.5052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE In asthma and other diseases, vitamin D insufficiency is associated with adverse outcomes. It is not known if supplementing inhaled corticosteroids with oral vitamin D-3 improves outcomes in patients with asthma and vitamin D insufficiency. OBJECTIVE To evaluate if vitamin D supplementation would improve the clinical efficacy of inhaled corticosteroids in patients with symptomatic asthma and lower vitamin D levels. DESIGN, SETTING, AND PARTICIPANTS The VIDA (Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma) randomized, double-blind, parallel, placebo-controlled trial studying adult patients with symptomatic asthma and a serum 25-hydroxyvitamin D level of less than 30 ng/mL was conducted across 9 academic US medical centers in the National Heart, Lung, and Blood Institute's AsthmaNet network, with enrollment starting in April 2011 and follow-up complete by January 2014. After a run-in period that included treatment with an inhaled corticosteroid, 408 patients were randomized. INTERVENTIONS Oral vitamin D-3 (100 000 IU once, then 4000 IU/d for 28 weeks; n = 201) or placebo (n = 207) was added to inhaled ciclesonide (320 g/d). If asthma control was achieved after 12 weeks, ciclesonide was tapered to 160 g/d for 8 weeks, then to 80 g/d for 8 weeks if asthma control was maintained. MAIN OUTCOMES AND MEASURES The primary outcomewas time to first asthma treatment failure (a composite outcome of decline in lung function and increases in use of beta-agonists, systemic corticosteroids, and health care). RESULTS Treatment with vitamin D-3 did not alter the rate of first treatment failure during 28 weeks (28%[95% CI, 21%-34%] with vitamin D-3 vs 29% [95% CI, 23%-35%] with placebo; adjusted hazard ratio, 0.9 [95% CI, 0.6-1.3]). Of 14 prespecified secondary outcomes, 9 were analyzed, including asthma exacerbation; of those 9, the only statistically significant outcome was a small difference in the overall dose of ciclesonide required to maintain asthma control (111.3 g/d [95% CI, 102.2-120.4 g/d] in the vitamin D-3 group vs 126.2 g/d [95% CI, 117.2-135.3 g/d] in the placebo group; difference of 14.9 g/d [95% CI, 2.1-27.7 g/d]). CONCLUSIONS AND RELEVANCE Vitamin D-3 did not reduce the rate of first treatment failure or exacerbation in adults with persistent asthma and vitamin D insufficiency. These findings do not support a strategy of therapeutic vitamin D-3 supplementation in patients with symptomatic asthma.
引用
收藏
页码:2083 / 2091
页数:9
相关论文
共 30 条
[11]   Semiparametric regression for the mean and rate functions of recurrent events [J].
Lin, DY ;
Wei, LJ ;
Yang, I ;
Ying, Z .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2000, 62 :711-730
[12]   Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma -: A randomized, controlled trial [J].
Malmstrom, K ;
Rodriguez-Gomez, G ;
Guerra, J ;
Villaran, C ;
Piñeiro, A ;
Wei, LX ;
Seidenberg, BC ;
Reiss, TF .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :487-+
[13]   The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial [J].
Martin, Richard J. ;
Szefler, Stanley J. ;
King, Tonya S. ;
Kraft, Monica ;
Boushey, Homer A. ;
Chinchilli, Vernon M. ;
Craig, Timothy J. ;
DiMango, Emily A. ;
Deykin, Aaron ;
Fahy, John V. ;
Israel, Elliot ;
Lazarus, Stephen C. ;
Lemanske, Robert F., Jr. ;
Leone, Frank T. ;
Pesola, Gene R. ;
Peters, Stephen P. ;
Sorkness, Christine A. ;
Szwejbka, Lisa A. ;
Wechsler, Michael E. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :73-80
[14]   Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion [J].
Nanzer, Alexandra M. ;
Chambers, Emma S. ;
Ryanna, Kimuli ;
Richards, David F. ;
Black, Cheryl ;
Timms, Peter M. ;
Martineau, Adrian R. ;
Griffiths, Christopher J. ;
Corrigan, Christopher J. ;
Hawrylowicz, Catherine M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (02) :297-+
[15]  
Peters SP, 2007, NEW ENGL J MED, V356, P2027
[16]   Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy [J].
Poon, AH ;
Laprise, C ;
Lemire, M ;
Montpetit, A ;
Sinnett, D ;
Schurr, E ;
Hudson, TJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (09) :967-973
[17]   Association of vitamin D receptor gene polymorphisms with childhood and adult asthma [J].
Raby, BA ;
Lazarus, R ;
Silverman, EK ;
Lake, S ;
Lange, C ;
Wjst, M ;
Weiss, ST .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (10) :1057-1065
[18]   An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Standardising Endpoints for Clinical Asthma Trials and Clinical Practice [J].
Reddel, Helen K. ;
Taylor, D. Robin ;
Bateman, Eric D. ;
Boulet, Louis-Philippe ;
Boushey, Homer A. ;
Busse, William W. ;
Casale, Thomas B. ;
Chanez, Pascal ;
Enright, Paul L. ;
Gibson, Peter G. ;
de Jongste, Johan C. ;
Kerstjens, Huib A. M. ;
Lazarus, Stephen C. ;
Levy, Mark L. ;
O'Byrne, Paul M. ;
Partridge, Martyn R. ;
Pavord, Ian D. ;
Sears, Malcolm R. ;
Sterk, Peter J. ;
Stoloff, Stuart W. ;
Sullivan, Sean D. ;
Szefler, Stanley J. ;
Thomas, Mike D. ;
Wenzel, Sally E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (01) :59-99
[19]   Integrating patient preferences into health outcomes assessment - The multiattribute Asthma Symptom Utility Index [J].
Revicki, DA ;
Leidy, NK ;
Brennan-Diemer, F ;
Sorensen, S ;
Togias, A .
CHEST, 1998, 114 (04) :998-1007
[20]   Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists [J].
Schatz, M ;
Sorkness, CA ;
Li, JT ;
Marcus, P ;
Murray, JJ ;
Nathan, RA ;
Kosinski, M ;
Pendergraft, TB ;
Jhingran, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (03) :549-556